Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

fezolinetant × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Specimen Handling 374 pembrolizumab 306 Magnetic Resonance Spectroscopy 306 Biopsy 237 Carboplatin 212 Cyclophosphamide 196 Cisplatin 172 Paclitaxel 157 Nivolumab 146 Gemcitabine 133 Radiotherapy 129 venetoclax 119 Bevacizumab 113 Dexamethasone 109 fludarabine 96 Rituximab 90 Fluorouracil 90 Pemetrexed 89 Oxaliplatin 88 durvalumab 87 Doxorubicin 86 Docetaxel 84 atezolizumab 82 Radiation 80 Prednisone 79 Lenalidomide 76 Ipilimumab 69 X-Rays 67 Leucovorin 66 Capecitabine 66

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06617455 2026-03-02

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡